EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between time to vagus nerve stimulation and seizure outcomes in adults with drug-resistant epilepsy

Emma Dunn, Daniel Colome, Adam Alayli, Vito Evola, Keaton Piper, Elliot Neal, Ushtar Amin, Yarema Bezchlibnyk

Epilepsy & Behavior Reports · 2026-11 · 100905

DOI: 10.1016/j.ebr.2026.100905 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsy & Behavior Reports, 2026-11. Verfasst von Emma Dunn und 7 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vagus nerve stimulation (VNS) is an established treatment for drug-resistant epilepsy, but the effect of implantation timing relative to epilepsy onset on outcomes remains unclear. We evaluated whether time from epilepsy onset to VNS implantation is associated with seizure outcomes in adults with drug-resistant epilepsy. We performed a retrospective cohort study of 89 adult patients with drug-resistant epilepsy who underwent VNS implantation with at least one year of follow-up. The primary outcome was responder status, defined as ≥50% reduction in seizure frequency at one year. Secondary outcomes included Engel classification, patient-reported worthwhile improvement, and seizure freedom. Associations between epilepsy duration and outcomes were evaluated using logistic and ordinal regression models. At one year, 59 of 89 patients (66%) met responder criteria, and 65 (73%) achieved Engel class I–III outcomes; 61 patients (69%) reported a worthwhile improvement in seizure burden. No statistically significant association was detected between time from epilepsy onset to VNS implantation and responder status (OR 1.00 per year, 95% CI 0.97–1.03; p = 0.94), Engel outcome (OR 0.99 per year, 95% CI 0.97–1.02; p = 0.66), or patient-reported improvement. Patients implanted more than 10 years after epilepsy onset had a responder rate similar to those implanted earlier (66% vs 67%). However, only 6 patients underwent implantation within 3 years of onset, so these data cannot determine whether earlier VNS provides greater benefit. Our findings suggest that patients with longstanding epilepsy may still derive meaningful benefit from VNS.

Zitieren

APA

Dunn, E., Colome, D., Alayli, A., Evola, V., Piper, K., Neal, E., Amin, U., & Bezchlibnyk, Y. (2026). Association between time to vagus nerve stimulation and seizure outcomes in adults with drug-resistant epilepsy. Epilepsy & Behavior Reports, 100905. https://doi.org/10.1016/j.ebr.2026.100905

Vancouver

Dunn E, Colome D, Alayli A, Evola V, Piper K, Neal E, et al. Association between time to vagus nerve stimulation and seizure outcomes in adults with drug-resistant epilepsy. Epilepsy & Behavior Reports. 2026:100905. doi:10.1016/j.ebr.2026.100905

BibTeX
@article{Dunn2026,
  author = {Dunn, Emma and Colome, Daniel and Alayli, Adam and Evola, Vito and Piper, Keaton and Neal, Elliot and Amin, Ushtar and Bezchlibnyk, Yarema},
  title = {Association between time to vagus nerve stimulation and seizure outcomes in adults with drug-resistant epilepsy},
  journal = {Epilepsy & Behavior Reports},
  year = {2026},
  pages = {100905},
  doi = {10.1016/j.ebr.2026.100905}
}
Kostenlos starten →